Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.48 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.43 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.41 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.41 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.41 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7563979 | 1.00 | FOLH1 (0.55) | FOLH1ALOX15BLMPMP22KMT2A | |
| SCHEMBL30148762 | 1.00 | FOLH1 (0.55) | FOLH1ALOX15BLMPMP22KMT2A | |
| SCHEMBL397257 | 1.00 | FOLH1 (0.55) | FOLH1ALOX15BLMPMP22KMT2A | |
| SCHEMBL27767761 | 0.98 | FOLH1 (0.54) | FOLH1ALOX15BLMPMP22KMT2A | |
| SCHEMBL30731560 | 0.97 | FOLH1 (0.52) | FOLH1ALOX15BLMPMP22KMT2A | |
| SCHEMBL5336140 | 0.94 | FOLH1 (0.55) | FOLH1ALOX15BLMPMP22KMT2A | |
| SCHEMBL5336146 | 0.94 | FOLH1 (0.55) | FOLH1ALOX15BLMPMP22KMT2A | |
| SCHEMBL32690574 | 0.93 | FOLH1 (0.55) | FOLH1ALOX15BLMPMP22KMT2A | |
| SCHEMBL31376469 | 0.92 | FOLH1 (0.48) | FOLH1ALOX15BLMPMP22KMT2A | |
| SCHEMBL31376475 | 0.92 | FOLH1 (0.48) | FOLH1ALOX15BLMPMP22KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230410977-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES | 2023-12-21 | — | — | US | claimed |
| WO-2022140565-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES (US) | 2022-06-30 | — | — | WO | claimed |
| US-20230410977-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES | 2023-12-21 | — | — | US | disclosed |
| US-20230124955-A1 | AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-04-20 | — | — | US | disclosed |
| EP-4074694-A1 | AMINO ACID-, PEPTIDE- AN POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AN USES THEREOF | Massachusetts Institute Of Technology (US) | 2022-10-19 | — | — | EP | disclosed |
| WO-2022140565-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES (US) | 2022-06-30 | — | — | WO | disclosed |
| CN-111560049-B | Zwitterionic polypeptide and derivative thereof and nano-drug based on zwitterionic polypeptide and derivative | 浙江大学 | 2022-05-17 | — | — | CN | disclosed |
| EP-3789043-A1 | EXTRACTION OF PLANT SOURCE \"MEDICINAL SOUP\" AND MANUAL PREPARATION OF \"HERBAL MEDICINE\" AND RELATED PRODUCTS | Institute of Basic Medical Sciences, Chinese Academi of Medical Sciences (CN) | 2021-03-10 | — | — | EP | disclosed |
| US-20200330501-A1 | AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-10-22 | — | — | US | disclosed |
| CN-111560049-A | Zwitterionic polypeptide and derivative thereof and nano-drug based on zwitterionic polypeptide and derivative | 浙江大学 | 2020-08-21 | — | — | CN | disclosed |
| US-10682374-B2 | Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof | MASSACHUSETTS INTSTITUTE OF TECHNOLOGY (US) | 2020-06-16 | — | — | US | disclosed |
| US-20060217321-A1 | Compositions to improve tic disorders | TAIYOKAGAKU CO., LTD. (JP) | 2006-09-28 | — | — | US | disclosed |
| US-20040058400-A1 | Multivalent and multispecific binding proteins, their manufacture and use | MEDICAL RESEARCH COUNCIL | 2004-03-25 | — | — | US | disclosed |
| US-6492123-B1 | POLYPEPTIDES COMPRISING A FIRST DOMAIN OF AN IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION, AND A SECOND DOMAIN OF AN IMMUNOGLOBULIN LIGHT CHAIN VARIABLE REGION, LINKED BUT INCAPABLE OF ASSOCIATING WITH EACH OTHER; ASSAY FOR ANTIGEN | MEDICAL RESEARCH COUNCIL (GB) | 2002-12-10 | — | — | US | disclosed |
| EP-0672142-B1 | MULTIVALENT AND MULTISPECIFIC BINDING PROTEINS, THEIR MANUFACTURE AND USE | MEDICAL RES COUNCIL (GB) | 2001-02-28 | — | — | EP | disclosed |
| US-5837242-A | POLYPEPTIDES | MEDICAL RESEARCH COUNCIL (GB) | 1998-11-17 | — | — | US | disclosed |
| EP-0726956-A1 | NOVEL HUMAN TRANSGLUTAMINASES | ZYMOGENETICS, INC. (US) | 1996-08-21 | — | — | EP | disclosed |
| EP-0672142-A1 | MULTIVALENT AND MULTISPECIFIC BINDING PROTEINS, THEIR MANUFACTURE AND USE | MEDICAL RESEARCH COUNCIL (GB) | 1995-09-20 | — | — | EP | disclosed |
| WO-1994013804-A1 | MULTIVALENT AND MULTISPECIFIC BINDING PROTEINS, THEIR MANUFACTURE AND USE | MEDICAL RESEARCH COUNCIL (GB) | 1994-06-23 | — | — | WO | disclosed |
| WO-1993013207-A2 | NOVEL HUMAN TRANSGLUTAMINASES | ZYMOGENETICS, INC. (US) | 1993-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200330501-A1 | AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF | APLNR, NPPA, ARGLU1 | FOLH1 823/4885ALOX15 1629/4885BLM 1004/4885 |
| US-20230124955-A1 | AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF | APLNR, NPPA, ARGLU1 | FOLH1 823/4885ALOX15 1629/4885BLM 1004/4885 |
| US-10682374-B2 | Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof | APLNR, NPPA, ARGLU1 | FOLH1 823/4885ALOX15 1629/4885BLM 1004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.